Literature DB >> 4043931

An immunopathologic evaluation of lymph nodes from monkey and man with acquired immune deficiency syndrome and related conditions.

P R Meyer, L D Ormerod, K G Osborn, L J Lowenstine, R V Hendrickson, R L Modlin, R E Smith, M B Gardner, C R Taylor.   

Abstract

Morphology and immunostaining of lymph nodes taken from rhesus monkeys and man are compared. The monkeys were inoculated with biologic materials known to transmit simian acquired immune deficiency syndrome (SAIDS) and the human biopsies were obtained from homosexual men with persistent generalized lymphadenopathy syndrome or acquired immune deficiency syndrome (AIDS). The lymph nodes from monkey and man share common immunohistochemical features, ranging from exhuberant follicular hyperplasia to lymphocyte depletion stage. The follicular hyperplasia differed from reactive controls by the larger follicular size and disorganization within the follicular centers as well as an increase in the number of cells with the T suppressor/cytotoxic phenotype. The lymphocyte depletion stage showed a loss of reactive follicles and small T lymphocytes with a predominance of mature monocytes/macrophages. Most monkeys and humans with the lymphocyte depletion morphology fulfilled the case definitions for AIDS and SAIDS while those with follicular hyperplasia usually had 'prodromal' findings. The simian agent is associated with alterations in lymph node morphology and immunostaining which parallel the changes seen in spontaneous human cases supporting a similar pathogenesis for AIDS and SAIDS.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4043931     DOI: 10.1002/hon.2900030308

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  7 in total

1.  Vesicular stomatitis virus-simian retrovirus type 2 vaccine protects macaques from detectable infection and B-cell destruction.

Authors:  Rajeev Gautam; Arun Iyer; Meredith Hunter; Arpita Das; Tessa Williams; Jason Dufour; Cristian Apetrei; K Gus Kousoulas; Preston A Marx
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

2.  Induction of simian acquired immune deficiency syndrome (SAIDS) with a molecular clone of a type D SAIDS retrovirus.

Authors:  G Heidecker; N W Lerche; L J Lowenstine; A A Lackner; K G Osborn; M B Gardner; P A Marx
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

3.  Simian retrovirus D serogroup 1 has a broad cellular tropism for lymphoid and nonlymphoid cells.

Authors:  D H Maul; C P Zaiss; M R MacKenzie; S M Shiigi; P A Marx; M B Gardner
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

4.  Toxicity and efficacy of 2',3'-dideoxycytidine in clinical trials of pigtailed macaques infected with simian retrovirus type 2.

Authors:  C C Tsai; K E Follis; M Yarnall; G A Blakley
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

5.  Distribution of a macaque immunosuppressive type D retrovirus in neural, lymphoid, and salivary tissues.

Authors:  A A Lackner; M H Rodriguez; C E Bush; R J Munn; H S Kwang; P F Moore; K G Osborn; P A Marx; M B Gardner; L J Lowenstine
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

6.  Isolation of a new serotype of simian acquired immune deficiency syndrome type D retrovirus from Celebes black macaques (Macaca nigra) with immune deficiency and retroperitoneal fibromatosis.

Authors:  P A Marx; M L Bryant; K G Osborn; D H Maul; N W Lerche; L J Lowenstine; J D Kluge; C P Zaiss; R V Henrickson; S M Shiigi
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

7.  In vitro properties and experimental pathogenic effect of three strains of feline immunodeficiency viruses (FIV) isolated from cats with terminal disease.

Authors:  A Moraillon; F Barré-Sinoussi; A Parodi; R Moraillon; C Dauguet
Journal:  Vet Microbiol       Date:  1992-04       Impact factor: 3.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.